268 related articles for article (PubMed ID: 24707857)
1. Nucleotide-binding oligomerization domain (NOD) inhibitors: a rational approach toward inhibition of NOD signaling pathway.
Jakopin Ž
J Med Chem; 2014 Aug; 57(16):6897-918. PubMed ID: 24707857
[TBL] [Abstract][Full Text] [Related]
2. Differential expression analysis of nuclear oligomerization domain proteins NOD1 and NOD2 in orange-spotted grouper (Epinephelus coioides).
Hou QH; Yi SB; Ding X; Zhang HX; Sun Y; Zhang Y; Liu XC; Lu DQ; Lin HR
Fish Shellfish Immunol; 2012 Nov; 33(5):1102-11. PubMed ID: 22982325
[TBL] [Abstract][Full Text] [Related]
3. Activation of the nucleotide oligomerization domain signaling pathway by the non-bacterially derived xanthone drug 5'6-dimethylxanthenone-4-acetic acid (Vadimezan).
Cheng G; Sun J; Fridlender ZG; Wang LC; Ching LM; Albelda SM
J Biol Chem; 2010 Apr; 285(14):10553-62. PubMed ID: 20118240
[TBL] [Abstract][Full Text] [Related]
4. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
Le Bourhis L; Benko S; Girardin SE
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
[TBL] [Abstract][Full Text] [Related]
5. Roles of NOD1 (NLRC1) and NOD2 (NLRC2) in innate immunity and inflammatory diseases.
Correa RG; Milutinovic S; Reed JC
Biosci Rep; 2012 Dec; 32(6):597-608. PubMed ID: 22908883
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B; Proell M; Wagner RN; Schwarzenbacher R; Kufer TA
Innate Immun; 2012 Feb; 18(1):100-11. PubMed ID: 21310790
[TBL] [Abstract][Full Text] [Related]
7. NOD1 and NOD2: Molecular targets in prevention and treatment of infectious diseases.
Pashenkov MV; Dagil YA; Pinegin BV
Int Immunopharmacol; 2018 Jan; 54():385-400. PubMed ID: 29207344
[TBL] [Abstract][Full Text] [Related]
8. The role of NOD1 and NOD2 in host defense against chlamydial infection.
Zou Y; Lei W; He Z; Li Z
FEMS Microbiol Lett; 2016 Sep; 363(17):. PubMed ID: 27421958
[TBL] [Abstract][Full Text] [Related]
9. Unleashing the therapeutic potential of NOD-like receptors.
Geddes K; Magalhães JG; Girardin SE
Nat Rev Drug Discov; 2009 Jun; 8(6):465-79. PubMed ID: 19483708
[TBL] [Abstract][Full Text] [Related]
10. Convergence of innate immunity and insulin resistance as evidenced by increased nucleotide oligomerization domain (NOD) expression and signaling in monocytes from patients with type 2 diabetes.
Shiny A; Regin B; Balachandar V; Gokulakrishnan K; Mohan V; Babu S; Balasubramanyam M
Cytokine; 2013 Nov; 64(2):564-70. PubMed ID: 24018334
[TBL] [Abstract][Full Text] [Related]
11. Identification of benzofused five-membered sultams, potent dual NOD1/NOD2 antagonists in vitro and in vivo.
Ma Y; Li X; Pei Y; Ye J; Wei X; Yang J; Si G; Tian J; Dong Y; Liu G
Eur J Med Chem; 2020 Oct; 204():112575. PubMed ID: 32731185
[TBL] [Abstract][Full Text] [Related]
12. Nod1 and Nod2 induce CCL5/RANTES through the NF-kappaB pathway.
Werts C; le Bourhis L; Liu J; Magalhaes JG; Carneiro LA; Fritz JH; Stockinger S; Balloy V; Chignard M; Decker T; Philpott DJ; Ma X; Girardin SE
Eur J Immunol; 2007 Sep; 37(9):2499-508. PubMed ID: 17705131
[TBL] [Abstract][Full Text] [Related]
13. Nucleotide-binding oligomerization domain containing 2: structure, function, and diseases.
Yao Q
Semin Arthritis Rheum; 2013 Aug; 43(1):125-30. PubMed ID: 23352252
[TBL] [Abstract][Full Text] [Related]
14. The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation.
Tattoli I; Travassos LH; Carneiro LA; Magalhaes JG; Girardin SE
Semin Immunopathol; 2007 Sep; 29(3):289-301. PubMed ID: 17690884
[TBL] [Abstract][Full Text] [Related]
15. THP-1 Cells and Pro-inflammatory Cytokine Production: An in Vitro Tool for Functional Characterization of NOD1/NOD2 Antagonists.
Jakopin Ž; Corsini E
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480368
[TBL] [Abstract][Full Text] [Related]
16. NOD-like receptors--pivotal guardians of the immunological integrity of barrier organs.
Rosenstiel P; Schreiber S
Adv Exp Med Biol; 2009; 653():35-47. PubMed ID: 19799110
[TBL] [Abstract][Full Text] [Related]
17. Characterization of three Nod-like receptors and their role in antimicrobial responses of goldfish (Carassius auratus L.) macrophages to Aeromonas salmonicida and Mycobacterium marinum.
Xie J; Hodgkinson JW; Katzenback BA; Kovacevic N; Belosevic M
Dev Comp Immunol; 2013 Mar; 39(3):180-7. PubMed ID: 23194927
[TBL] [Abstract][Full Text] [Related]
18. Structural models of zebrafish (Danio rerio) NOD1 and NOD2 NACHT domains suggest differential ATP binding orientations: insights from computational modeling, docking and molecular dynamics simulations.
Maharana J; Sahoo BR; Bej A; Jena I; Parida A; Sahoo JR; Dehury B; Patra MC; Martha SR; Balabantray S; Pradhan SK; Behera BK
PLoS One; 2015; 10(3):e0121415. PubMed ID: 25811192
[TBL] [Abstract][Full Text] [Related]
19. Role of NOD1/NOD2 receptors in Fusobacterium nucleatum mediated NETosis.
Alyami HM; Finoti LS; Teixeira HS; Aljefri A; Kinane DF; Benakanakere MR
Microb Pathog; 2019 Jun; 131():53-64. PubMed ID: 30940608
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization, expression and functional analysis of NOD1, NOD2 and NLRC3 in Nile tilapia (Oreochromis niloticus).
Gao FY; Pang JC; Lu MX; Yang XL; Zhu HP; Ke XL; Liu ZG; Cao JM; Wang M
Fish Shellfish Immunol; 2018 Feb; 73():207-219. PubMed ID: 29242132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
